Migraine is a chronic neurovascular disorder that, in Western countries, affects approximately 15% of the general population [1] . The aetiology of migraine is still unknown but several studies support a strong genetic basis for the disease [2] . Mutations in the CACNA1A and ATP1A2 genes are associated with familial hemiplegic migraine, a rare subtype of migraine with aura [3, 4] . The genes involved in the more common form of migraine, like migraine with and without aura, are still unknown.
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Abstract We examined the distribution of HLA-DRB1 alleles in a cohort of 255 Italian migraine patients and in a control group of 325 healthy subjects. The frequency of DRB1*12 allele was found to be significantly reduced (p=0.02) in patients with migraine while the DRB1*16 allele was significantly increased (p=0.04) in comparison with controls. When the patients were divided into disease subgroups (migraine with and without aura), HLA-DRB1**16 allele was significantly increased (p<0.05) only in migraine without aura patients. We conclude that, in Italian patients, migraine is associated with differ-ent alleles of the HLA-DRB1 locus. Our data suggest the presence of a genetic susceptibility factor for migraine within the HLA region.
Materials and methods
Two hundred and fifty-five consecutive migraine patients (77 males, 178 women; mean age±SD=40.87±13.10 years) attending the Headache Center of the University of Turin (Italy), were involved in the study. The diagnosis of migraine was made according to the International Classification of Headache Disorders (ICHD-II) criteria [11] . For additional analyses, migraine patients were divided into 2 subgroups: (A) migraine without aura (ICHD-II code 1.1), 214 patients (65 males, 149 females; mean age±SD=41.5±12.0 years); and (B) migraine with aura (ICHD-II code 1.2), 41 patients (12 males, 29 females; mean age±SD=36.4±13.6 years). A group of 325 age and geographically matched healthy subjects (151 males, 174 females, mean age±SD=41.96±14.86 years) served as control. The controls were blood donors and were screened by a neurologist specialised in headaches in order to exclude migraine and/or cluster headache. The protocol of this study was reviewed and approved by the Medical Ethics Committee of the San Giovanni Battista Hospital of Turin and written informed consent was obtained from all participants.
Genomic DNA was extracted from EDTA-treated blood using a commercial DNA extraction kit (QiAmp blood kit; Kagan, Crawley, UK). HLA-DRB1 typing was performed at the two-digit level by PCR amplification using specific probes and primers (Dynal Biotech Ltd., Bromborough, Wirral, UK). The Hardy-Weinberg equilibrium was verified for all tested populations. Statistical analyses were performed using SigmaStat version 1.0 (Jandel Corp., 1994, San Rafael, CA). A level of p<0.05 was accepted as statistically significant. Table 1 shows the distribution of HLA-DRB1 alleles in migraine patients and controls. The phenotypic frequencies of HLA-DRB1 alleles were similar to those previously found in the Italian population [12] . In patients with migraine, the frequency of the HLA-DRB1*12 allele was found to be significantly lower than in controls (χ 2 =5.03, p=0.025, OR: 0.28, 95% CI: 0.08-0.88). The frequency of HLA-DRB1*16 was significantly higher (χ 2 =4.10, p=0.043, OR: 1.80, 95% CI: 1.02-3.19) in migraine patients. No significant difference was found in the remaining alleles. Table 2 shows the comparison of HLA-DRB1 alleles between migraine subgroups and healthy controls. In 
Results

Discussion
Our study shows the presence of a significant association between alleles of the HLA-DRB1 gene and migraine. Subjects carrying the *12 allele of this gene present a significant reduction in the risk for migraine, suggesting a protective role for the disease. On the contrary, the carriage of the *16 allele is associated with a two-fold increase in disease risk. When the migraine patients were divided into subgroups (migraine with and without aura), only migraine without aura patients presented a significant increase of the *16 allele. These alleles may be considered as risk factors for migraine without aura in the Italian population. In a previous study, Martelletti et al. [13] genotyped 45 migraine patients for HLA-DRB1 alleles and found no significant difference with controls. The number of patients examined in this study was probably too low for the detection of a statistically significant difference. The most likely explanation of our data is that the DRB1 locus is in linkage disequilibrium (LD) with other genetic polymorphisms which are responsible for this association. The DRB1 gene is located on chromosome 6p21, within the HLA-Class III region, and this region is characterised by a high LD [14] . Further studies, using different methods for HLA analysis, are needed to confirm the presence of susceptibility genes for migraine in this genomic region.
